Your browser doesn't support javascript.
loading
Repeated Administration of Opra Kappa (LY2456302), a Novel, Short-Acting, Selective KOP-r Antagonist, in Persons with and without Cocaine Dependence.
Reed, Brian; Butelman, Eduardo R; Fry, Rebecca S; Kimani, Rachel; Kreek, Mary Jeanne.
Affiliation
  • Reed B; Laboratory of the Biology of Addictive Diseases, Rockefeller University, New York, NY, USA.
  • Butelman ER; Laboratory of the Biology of Addictive Diseases, Rockefeller University, New York, NY, USA.
  • Fry RS; Laboratory of the Biology of Addictive Diseases, Rockefeller University, New York, NY, USA.
  • Kimani R; Laboratory of the Biology of Addictive Diseases, Rockefeller University, New York, NY, USA.
  • Kreek MJ; Laboratory of the Biology of Addictive Diseases, Rockefeller University, New York, NY, USA.
Neuropsychopharmacology ; 43(4): 739-750, 2018 03.
Article in En | MEDLINE | ID: mdl-28857070

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrrolidines / Benzamides / Receptors, Opioid, kappa / Cocaine-Related Disorders / Narcotic Antagonists Type of study: Diagnostic_studies / Prognostic_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Neuropsychopharmacology Journal subject: NEUROLOGIA / PSICOFARMACOLOGIA Year: 2018 Document type: Article Affiliation country: United States Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrrolidines / Benzamides / Receptors, Opioid, kappa / Cocaine-Related Disorders / Narcotic Antagonists Type of study: Diagnostic_studies / Prognostic_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Neuropsychopharmacology Journal subject: NEUROLOGIA / PSICOFARMACOLOGIA Year: 2018 Document type: Article Affiliation country: United States Country of publication: United kingdom